Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2386 to 2400 of 9026 results

  1. Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people of any age [ID6400]

    In development Reference number: GID-TA11509 Expected publication date:  24 February 2027

    Technology appraisal guidance
    In development

  2. Anitocabtagene autoleucel for treating relapsed or refractory multiple myeloma ID6549

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  3. Cryoablation for Desmoid-type Fibromatosis

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. MRI-guided laser interstitial thermal therapy for early prostate cancer

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Transcatheter Tricuspid Valve Replacement

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. Infrared lasers for treating onychomycosis

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  7. Spirecut's Sono-Instruments to treat carpal tunnel syndrome and trigger finger

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  8. Percutaneous intraductal radiofrequency ablation for malignant biliary obstruction

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  9. Laparoscopic lumbar sympathectomy for foot hyperhidrosis

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  10. External stimulation of the auricular branch of the vagus nerve

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  11. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for glycemic control

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  12. Tucatinib with trastuzumab emtansine for treating HER2-positive unresectable or advanced breast cancer after a taxane, trastuzumab or both together [ID6165]

    Awaiting development Reference number: GID-TA11110 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  13. Benegrastim for treating chemotherapy-induced neutropenia in people with breast cancer [TSID11769]

    Awaiting development Reference number: GID-TA11088 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Rucaparib for treating hormone-relapsed metastatic prostate cancer with homologous recombination deficiency after 1 therapy [TSID10764]

    Awaiting development Reference number: GID-TA11049 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Abatacept for treating active idiopathic inflammatory myopathies [TSID10095]

    Awaiting development Reference number: GID-TA10993 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development